Acasti Pharma Inc.
SEC Filing List
ACST CIK: 0001444192
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | Toppan Merrill/FA | 02/17/2026 | |||
| SCHEDULE 13G/A | Toppan Merrill/FA | 02/13/2026 | |||
| 8-K | Current report filing | Grace Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 02/12/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Grace Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 02/12/2026 | |
| SCHEDULE 13G/A | M2 COMPLIANCE LLC /fa | 01/28/2026 | |||
| 4 | Statement of changes in beneficial owner... | Kottayil George | Broadridge Financial Solutions, Inc. /fa | 01/12/2026 | |
| 4 | Statement of changes in beneficial owner... | Kavuru Vimal | Broadridge Financial Solutions, Inc. /fa | 01/12/2026 | |
| 8-K | Current report filing | Grace Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 01/12/2026 | |
| 4 | Statement of changes in beneficial owner... | Davis A Brian | Broadridge Financial Solutions, Inc. /fa | 01/12/2026 | |
| 4 | Statement of changes in beneficial owner... | Neugeboren Edward | Broadridge Financial Solutions, Inc. /fa | 01/12/2026 | |
| No record found. | |||||
| Load More | |||||
